1.
Ross DM, Bartley PA, Goyne J, Morley AA, Seymour JF, Grigg AP. Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features. Haematologica [Internet]. 2011Nov.4 [cited 2026Nov.16];96(11):1720-2. Available from: https://haematologica.org/article/view/6134